about
IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptabilityImmediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomesProkineticins: novel mediators of inflammatory and contractile pathways at parturition?Sex-Differences in the Metabolic Health of Offspring of Parents with Diabetes: A Record-Linkage StudyA blinded randomised placebo-controlled trial investigating the efficacy of morphine analgesia for procedural pain in infants: Trial protocolPlanned Repeat Cesarean Section at Term and Adverse Childhood Health Outcomes: A Record-Linkage StudyInflammatory pathways in the mechanism of parturitionVaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.Written versus verbal consent: a qualitative study of stakeholder views of consent procedures used at the time of recruitment into a peripartum trial conducted in an emergency setting.Post-weaning diet determines metabolic risk in mice exposed to overnutrition in early life.Human cathelicidin production by the cervixTrial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome?Outcomes of induction of labour in women with previous caesarean delivery: a retrospective cohort study using a population database.Efficacy of metformin in pregnant obese women: a randomised controlled trial.Pregnancy in obese mice protects selectively against visceral adiposity and is associated with increased adipocyte estrogen signalling15-epi-lipoxin A4 reduces the mortality of prematurely born pups in a mouse model of infection-induced preterm birth.Ultrasound-guided intrauterine injection of lipopolysaccharide as a novel model of preterm birth in the mouseProkineticin 1 induces inflammatory response in human myometrium: a potential role in initiating term and preterm parturitionCrosstalk between monocytes and myometrial smooth muscle in culture generates synergistic pro-inflammatory cytokine production and enhances myocyte contraction, with effects opposed by progesterone.Outcomes of elective induction of labour compared with expectant management: population based studyPrescribing Exercise and Lifestyle Training for High Risk Women in Pregnancy and Early Post-partum-Is It Worth It?Convergence in insulin resistance between very severely obese and lean women at the end of pregnancy.Health Behaviours during Pregnancy in Women with Very Severe ObesityPlacental hormone profiles as predictors of preterm birth in twin pregnancy: A prospective cohort studyEffect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial.Multiple Measures of Fixation on Social Content in Infancy: Evidence for a Single Social Cognitive Construct?Recruiting and consenting into a peripartum trial in an emergency setting: a qualitative study of the experiences and views of women and healthcare professionalsPreterm labour. Cervical function and prematurity.The role of therapeutic optimism in recruitment to a clinical trial in a peripartum setting: balancing hope and uncertainty.Prokineticin 1 induces a pro-inflammatory response in murine fetal membranes but does not induce preterm delivery.Inflammation and pregnancy.Decidual neutrophil infiltration is not required for preterm birth in a mouse model of infection-induced preterm labor.Inflammatory pathways in female reproductive health and disease.Chlamydia in gynecologic practice.Obesity, pregnancy, inflammation, and vascular function.Fetal fibronectin as a predictor of spontaneous preterm birth: a European perspective.The efficacy of fetal fibronectin testing in minimising hospital admissions, length of hospital stay and cost savings in women presenting with symptoms of pre-term labour.Factors influencing women's views on the acceptability and experience of being opportunistically screened for Chlamydia trachomatis in hospital settings.An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.Anti-inflammatory mediators as physiological and pharmacological regulators of parturition.
P50
Q21261343-2E00C426-7510-40C6-B595-591C5CBF564DQ24202066-AE011E49-0E13-484C-B4FD-F493E20D28E0Q27692018-98D9333C-A225-4B54-B00E-B8DB00D05A79Q28547479-8CD51B07-52B5-40D3-BC21-2588C52ED3FBQ28583562-1D41EA20-66E1-4E34-BCC8-9B1793D0C70AQ28602640-EB001A25-D9B0-4502-9F85-5B7F7457E539Q33287762-E3115C2A-FB82-4AD5-B03B-E5D256A31985Q33607661-D82C439E-CBEE-4417-91D5-03ED46BD6A9FQ33724379-81A1124D-B056-411E-BBEF-360067C27FA6Q33994482-EBA33ED9-3E1E-4BBE-842B-B952B19DE81CQ33999248-CB991724-D067-4E25-BFBD-26AFF41029CDQ34367437-65628356-98A8-4BF4-A1F9-959980F44AE2Q34658425-10C6A23D-5B69-4499-A3F5-24614EBE4926Q34981504-AD6BE494-1377-4121-B5B3-73D66F1F2788Q35147788-CFF6234B-9145-4641-A32A-E771AE183BEBQ35236981-CD34670C-C8D9-4D98-81BF-0AAAB8D749DCQ35568267-AEEB2F3C-E416-4AEA-BDB7-1956808CD94CQ35587288-0B810ACE-07C3-4B10-926D-26024AD26774Q35897959-C19DCB13-D49C-450F-A747-E345CFEEB99BQ35951641-0C4B98EF-1534-4F54-BD87-82B855C74504Q36086108-EEF4F8F2-EA1F-4026-A1AC-5A195918CA99Q36109241-9E37C3B3-F756-4421-80A0-EAAD2B8B8D3CQ36246730-BEA76A60-6D1F-487A-8662-B71E05212FDBQ36302503-94F40E29-8431-4723-B5D7-F0474961BF11Q36355726-A6826841-FBB7-49E5-96DE-176A1419CBC4Q36604145-0BEA1D94-E310-48CA-AE64-6A9CC28C6F00Q36785786-B755BA5E-0088-4C02-9E01-A3453D75D107Q36816395-7FFE1027-91CB-4C44-A264-AA92221ABC14Q36955261-B9D6583E-F710-4936-8422-27EDD70CA942Q37249396-178290C6-77B4-472C-BF17-A1DA6E034BA6Q37390203-C58F9E86-907F-4007-AE99-4CBD909F5BA7Q37599663-8EEBA021-F665-4E98-A22D-2F4C82CCD997Q37606140-341BE913-BCC6-44CE-9116-3804952A071DQ37608361-6442825F-8129-41C5-A481-04B8F1A99F82Q37705670-7700E3C2-201E-493B-AE1C-5F5CAF697774Q37776498-AB533014-867C-4679-BDB2-0E4B8C4D53C0Q37815177-4A151087-A4FD-4CC8-AF99-C6BB34A29955Q37860598-1EEBD59F-9610-4022-83E2-1D4C3074717BQ37866147-8E0564B7-ECF9-4456-9544-A7D338CBE790Q37927081-00E3F36B-87B8-44AA-8CF5-1B95245007D7
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6031-6953
@en
name
Jane E Norman
@ast
Jane E Norman
@en
Jane E Norman
@nl
type
label
Jane E Norman
@ast
Jane E Norman
@en
Jane E Norman
@nl
prefLabel
Jane E Norman
@ast
Jane E Norman
@en
Jane E Norman
@nl
P106
P31
P496
0000-0001-6031-6953